Dr. Inderpreet S. Saini, MD

Dr. Saini practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Saini's NPI, 1699924332, was assigned on September 18, 2008. Dr. Saini graduated from Drexel University College Of Medicine in 2008. Dr. Saini holds California license A110057.

Dr. Saini's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Saini's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Saini is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saini practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Saini's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Saini is board certified in internal medicine by the American Board of Internal Medicine. Dr. Saini is licensed in California.

Dmand AI lists acute kidney failure, acute sinusitis, acute skin infection, acute stomach ulcer, anemia, arthritis, cardiac arrhythmia and cellulitis among the conditions Dr. Saini treats.

CMS data shows 980 Medicare services from Dr. Saini across 9 procedure codes in 2024, for 417 Medicare patients. Medicare paid $92,404 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 417 Medicare patients who saw Dr. Saini in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saini's median patient age at 58, with 54% women.

In 2024, Dr. Saini wrote 444 Medicare Part D claims for 193 patients. 85% of them were for generic drugs. CMS names the drug for 145 of them, across 10 drugs with 11 or more claims each, at $8,656 in total drug cost. In 2023, CMS named 196 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Saini for performance year 2024, reported as part of a group. Dr. Saini accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Saini, published from 2020 to 2023. Dr. Saini's most frequent co-authors are Gregg Curtis Fonarow, MD, Alex Guzner and Tamara B. Horwich, MD.

CMS Open Payments shows 3 general payments to Dr. Saini from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $189.

Dr. Saini graduated from Drexel University College Of Medicine in 2008.

Dr. Saini is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.